Indication
Thromboembolism due to prosthetic heart valves
Thromboembolism due to prosthetic heart valves is a cardiovascular complication characterized by the formation of blood clots on or around an artificial heart valve and their subsequent dislodgement into the systemic or pulmonary circulation. Read more about Thromboembolism due to prosthetic heart valves
32 drugs 28 manufacturers
Drugs that treat it
Common Thromboembolism due to prosthetic heart valves therapies.
WARFARIN SODIUM
WARFARIN SODIUM
WARFARIN SODIUM
DIPYRIDAMOLE
WARFARIN SODIUM
WARFARIN SODIUM
DIPYRIDAMOLE
WARFARIN SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonThromboembolism due to prosthetic heart valves is a cardiovascular complication characterized by the formation of blood clots on or around an artificial heart valve and their subsequent dislodgement into the systemic or pulmonary circulation.
This condition primarily affects patients with mechanical or bioprosthetic valve replacements, driven by altered hemodynamics, foreign material thrombogenicity, endothelial disruption, and shear stress–induced platelet activation and coagulation cascade triggering.
Clinically, it manifests either as local valve thrombosis leading to valvular obstruction and acute heart failure, or as distal embolic phenomena causing ischemic stroke, transient ischemic attack, or systemic organ infarction.
- nih.gov
Thromboembolism due to prosthetic heart valves is a cardiovascular complication characterized by the formation of blood clots on or around an artificial heart valve and their subsequent dislodgement into the systemic or pulmonary circulation This condition primarily affects patients with mechanical or bioprosthetic valve replacements, driven by altered hemodynamics, foreign material thrombogenicity, endothelial disruption, and shear stress–induced platelet activation and coagulation cascade trig...
- nih.gov
Thromboembolism due to prosthetic heart valves is a cardiovascular complication characterized by the formation of blood clots on or around an artificial heart valve and their subsequent dislodgement into the systemic or pulmonary circulation Clinically, it manifests either as local valve thrombosis leading to valvular obstruction and acute heart failure, or as distal embolic phenomena causing ischemic stroke, transient ischemic attack, or systemic organ infarction
- nih.gov
This condition primarily affects patients with mechanical or bioprosthetic valve replacements, driven by altered hemodynamics, foreign material thrombogenicity, endothelial disruption, and shear stress–induced platelet activation and coagulation cascade triggering
- thevalveclub.com.br
This condition primarily affects patients with mechanical or bioprosthetic valve replacements, driven by altered hemodynamics, foreign material thrombogenicity, endothelial disruption, and shear stress–induced platelet activation and coagulation cascade triggering
- nih.gov
Clinically, it manifests either as local valve thrombosis leading to valvular obstruction and acute heart failure, or as distal embolic phenomena causing ischemic stroke, transient ischemic attack, or systemic organ infarction
- nih.gov
Clinically, it manifests either as local valve thrombosis leading to valvular obstruction and acute heart failure, or as distal embolic phenomena causing ischemic stroke, transient ischemic attack, or systemic organ infarction
Personalize your experience
Follow Thromboembolism due to prosthetic heart valves and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.